Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000826069 | SCV000967563 | uncertain significance | not specified | 2018-04-06 | criteria provided, single submitter | clinical testing | The p.Thr17024Ala variant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 2/111250 of European chromosome s by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs769094173). Computational prediction tools and conservation analysis sug gest that the p.Thr17024Ala variant may impact the protein, though this informat ion is not predictive enough to determine pathogenicity. In summary, the clinica l significance of the p.Thr17024Ala variant is uncertain. ACMG/AMP Criteria appl ied: PM2; PP3. |
Gene |
RCV004726697 | SCV005334902 | uncertain significance | not provided | 2023-05-19 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; Has not been previously published as pathogenic or benign to our knowledge |